Xact Kapitalforvaltning’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Xact Kapitalforvaltning's PFE Position: Q1 2020 in Review
Xact Kapitalforvaltning increased its Pfizer (PFE) stake by 1.3% in Q1 2020, buying an estimated $565K and bringing the position to 1,302,745 shares worth $40.3M. The position accounts for 0.86% of the portfolio, ranked #19.
Xact Kapitalforvaltning first reported a position in PFE in Q3 2016 and has held it in 15 quarters since. The position peaked at $50.2M in Q3 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.
- Xact Kapitalforvaltning held 1,302,745 shares of Pfizer worth $40.3M as of Q1 2020.
- Xact Kapitalforvaltning bought 16,575 Pfizer shares in Q1 2020, an estimated $565K.
- Pfizer made up 0.86% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #19 holding.
- Xact Kapitalforvaltning first reported a position in Pfizer in Q3 2016 and has held it in 15 quarters since.
- Xact Kapitalforvaltning's Pfizer position peaked at $50.2M in Q3 2018.
- 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.
Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.